Medicine directory
Oncology medicines, treatment questions, and official source links.
Use these pages to prepare for a doctor conversation or second opinion. They are educational and do not replace the prescribing information or your oncology team.
Search medicines
Start with high-value cancer medicines and expand by specialty.
Search by generic name, brand name, class, biomarker, or topic.
Rituximab
RituxanUsed in selected blood cancers and immune conditions depending on diagnosis and treatment plan.
EGFR tyrosine kinase inhibitorOsimertinib
TagrissoUsed in certain EGFR-mutated non-small cell lung cancer settings.
HER2-directed antibody-drug conjugateFam-trastuzumab deruxtecan
EnhertuUsed in selected HER2-expressing cancers depending on diagnosis, prior therapy, and biomarker status.
HER2-directed monoclonal antibodyTrastuzumab
HerceptinUsed in HER2-positive cancers in specific treatment settings.
PARP inhibitorOlaparib
LynparzaUsed in selected cancers with DNA repair pathway relevance depending on biomarker and treatment setting.
PD-1 inhibitor immunotherapyNivolumab
OpdivoUsed in several solid tumors and blood cancers depending on cancer type, stage, and prior treatment.
PD-1 inhibitor immunotherapyPembrolizumab
KeytrudaUsed across multiple cancer types depending on diagnosis, stage, biomarkers, and treatment setting.
PD-L1 inhibitor immunotherapyAtezolizumab
TecentriqUsed in selected cancers where immunotherapy is part of an approved treatment pathway.
Platinum chemotherapyCarboplatin
ParaplatinUsed in many cancer treatment plans, often with other chemotherapy, immunotherapy, or targeted therapy.
Taxane chemotherapyPaclitaxel
TaxolUsed in many cancer treatment plans, often in combination with other medicines.
Trop-2-directed antibody-drug conjugateSacituzumab govitecan
TrodelvyUsed in selected advanced cancers after specific prior treatments.
Tyrosine kinase inhibitorImatinib
GleevecUsed in selected blood cancers and tumors where the relevant molecular target is present.